- Home
- RSLS vs KXIN Comparison
RSLS vs KXIN Comparison
Compare RSLS & KXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSLS
- KXIN
- Stock Information
- Founded
- RSLS 2002
- KXIN 2015
- Country
- RSLS United States
- KXIN China
- Employees
- RSLS N/A
- KXIN N/A
- Industry
- RSLS Medical/Dental Instruments
- KXIN Retail-Auto Dealers and Gas Stations
- Sector
- RSLS Health Care
- KXIN Consumer Discretionary
- Exchange
- RSLS Nasdaq
- KXIN Nasdaq
- Market Cap
- RSLS 3.2M
- KXIN 2.8M
- IPO Year
- RSLS 2007
- KXIN N/A
- Fundamental
- Price
- RSLS $3.57
- KXIN $1.39
- Analyst Decision
- RSLS Hold
- KXIN
- Analyst Count
- RSLS 1
- KXIN 0
- Target Price
- RSLS N/A
- KXIN N/A
- AVG Volume (30 Days)
- RSLS 43.6K
- KXIN 258.0K
- Earning Date
- RSLS 03-31-2025
- KXIN 01-01-0001
- Dividend Yield
- RSLS N/A
- KXIN N/A
- EPS Growth
- RSLS N/A
- KXIN N/A
- EPS
- RSLS N/A
- KXIN N/A
- Revenue
- RSLS $8,183,000.00
- KXIN $12,679,000.00
- Revenue This Year
- RSLS $17.47
- KXIN N/A
- Revenue Next Year
- RSLS $20.00
- KXIN N/A
- P/E Ratio
- RSLS N/A
- KXIN N/A
- Revenue Growth
- RSLS N/A
- KXIN N/A
- 52 Week Low
- RSLS $3.23
- KXIN $1.20
- 52 Week High
- RSLS $29.00
- KXIN $29.52
- Technical
- Relative Strength Index (RSI)
- RSLS 33.36
- KXIN 36.15
- Support Level
- RSLS $3.23
- KXIN $1.30
- Resistance Level
- RSLS $3.92
- KXIN $1.49
- Average True Range (ATR)
- RSLS 0.31
- KXIN 0.12
- MACD
- RSLS -0.08
- KXIN 0.03
- Stochastic Oscillator
- RSLS 19.21
- KXIN 14.95
About RSLS ReShape Lifesciences Inc.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.
About KXIN Kaixin Auto Holdings
Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company primarily generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.